首页> 外文期刊>Cancer biology & therapy >MiR-422a weakened breast cancer stem cells properties by targeting PLP2
【24h】

MiR-422a weakened breast cancer stem cells properties by targeting PLP2

机译:MiR-422A通过靶向PLP2弱化乳腺癌干细胞性能

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: This study investigated miR-422a and PLP2 expressions in breast cancer cells and breast cancer stem cells (BCSCs). Besides, their influences on polymorphism changes were observed. Methods: Flow cytometry and fluorescence-activated cell sorting was performed and CD24~-7CD44~+ cells were sorted from breast cancer cells and recognized as BCSCs. Microarray was applied to search for the differentially expressed miRNAs and mRNAs between MCF7 and BCSCs. The aberrant expression of miR-422a and PLP2 was further confirmed by RT-qPCR and the direct targeted relationship was verified by dual-luciferase reporter assay. After in vitro transfection, the expression of miR-422a and PLP2 were manipulated and biological functions of BMSCs were compared with CCK-8, colony formation and sphere formation assay. The tumorigenesis ability of transfected BMSCs was also investigated in NOD/SCID tumor mice models. Results: BMSCs were successfully established from MCF7 cells and miR-422a expression was downregulated while PLP2 level decreased in BMSCs. MiR-422a directly targets the 3'UTR of PLP2 and suppressed its expression. Besides, the up-regulation of miR-422a contributed to weakened ability of proliferation and microsphere formation of BMSCs, while PLP2 overexpression facilitated those biological abilities. Tumorigenesis of BMSCs in mice models was impaired by either overexpression of miR-442a or silencing of PLP2. Conclusion: Up-regulation of miR-422a attenuated microsphere formation, proliferation and tumor formation of breast cancer stem cells via suppressing the PLP2 expression.
机译:目的:本研究研究了乳腺癌细胞和乳腺癌干细胞(BCSCs)中的miR-422a和plp2表达。此外,观察到它们对多态性变化的影响。方法:进行流式细胞术和荧光激活的细胞分选,并从乳腺癌细胞中对CD24〜-7CD44〜+细胞进行分类,并被认为是BCSCs。应用微阵列以在MCF7和BCSC之间搜索差异表达的miRNA和MRNA。通过RT-QPCR进一步证实miR-422a和PLP2的异常表达,并通过双荧光素酶报告结果验证了直接靶向关系。在体外转染后,将MiR-422a和PLP2的表达被操纵,并将BMSCs的生物功能与CCK-8,菌落形成和球形形成测定进行比较。在点击/ SCID肿瘤小鼠模型中也研究了转染BMSCs的肿瘤瘤功能能力。结果:从MCF7细胞成功建立了BMSCs,并在BMSCs中降低了MIR-422A表达。 miR-422a直接针对PLP2的3'URR并抑制其表达。此外,MiR-422a的上调有助于削弱BMSC的增殖和微球形成能力,而PLP2过表达促进了那些生物能力。通过MiR-442a的过表达或PLP2沉默的过表达抑制小鼠模型中BMSC的肿瘤引发。结论:通过抑制PLP2表达,MiR-422A减毒衰减微球形成,增殖和肿瘤形成的抑制微球体形成,增殖和肿瘤形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号